← Back to Search

Contact Lens

Control Lenses for Near-sightedness

N/A
Waitlist Available
Led By Pete Kollbaum
Research Sponsored by Coopervision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial tests a new type of contact lens to see if it works well for everyday wearers.

Who is the study for?
This trial is for adults over 18 who are near-sighted with a prescription between -0.50 D to -6.00 D, have had an eye exam in the last year, can see at least 20/40 with their current glasses or contacts, and use comfilcon A lenses regularly. They must understand the consent form and follow the study schedule.Check my eligibility
What is being tested?
The study is testing reusable soft contact lenses made using a new process compared to those made by the current process. Participants will wear these test lenses in their daily lives to evaluate performance.See study design
What are the potential side effects?
Potential side effects may include discomfort while wearing the lenses, dry eyes, redness or irritation of the eye. These are common reactions that some people might experience when trying new contact lenses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Acuity

Trial Design

2Treatment groups
Experimental Treatment
Group I: Test LensesExperimental Treatment1 Intervention
Participants will wear Test Lenses for 4 weeks
Group II: Control LensesExperimental Treatment1 Intervention
Participants will wear Control Lenses for 4 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control Lenses (comfilcon A with current process)
2023
N/A
~80
Test Lenses (comfilcon A with novel process)
2023
N/A
~80

Find a Location

Who is running the clinical trial?

Coopervision, Inc.Lead Sponsor
155 Previous Clinical Trials
13,752 Total Patients Enrolled
Pete KollbaumPrincipal InvestigatorIndiana University
1 Previous Clinical Trials
19 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for participants to join this experiment currently?

"The details of this medical study, which were initially posted on November 14th 2021, confirm it is actively recruiting. Recent updates to the clinical trial occurrred on December 8th 2023."

Answered by AI

How many individuals are eligible to partake in the experiment?

"This clinical trial needs 72 qualified participants. The eligible subjects can join at either the Clinical Optics Research Lab in Bloomington, Indiana or SUNY College of Optometry's Clinical Vision Research Center located in New york City."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Clinical Evaluation of Reusable Soft Contact Lenses
2023. "Clinical Evaluation of Reusable Soft Contact Lenses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06119191.
All > Indianapolis
~51 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top